TGA cracks down on illegal peptide and steroid sales
17 Aug 2026
The properties were allegedly linked to a social media influencer who had imported, relabelled and promoted the products online for sale.
The seized products included retatrutide, CJC-1295 and the Wolverine Stack, which contains BPC-157 and TB-500.
The influencer had previously received a warning from the TGA. Search warrants were carried out at the two properties on 4 August 2026. NSW Police also allegedly found and seized cannabis at one of the properties.
In Australia, it is unlawful to import, advertise, manufacture or supply unapproved peptide products.
The TGA warns that many peptides promoted through websites, social media, messaging apps and overseas suppliers have not been assessed for safety, quality or effectiveness.
This means consumers may not know exactly what they are buying or using. Unapproved peptide products may also cause serious health problems, including liver damage, severe allergic reactions and inflammation.
Professor Anthony Lawler, head of the TGA, said people who sell or promote unapproved therapeutic goods online are not outside Australian law.
The TGA can take enforcement action against people involved in the unlawful supply or promotion of these products. Possible consequences include infringement notices, civil or criminal penalties and product seizures.
Under the Therapeutic Goods Act 1989, breaches can attract significant penalties, including civil penalties of up to $1.82 million per breach for individuals and $18.2 million for corporations. Criminal offences can also carry penalties of up to seven years’ imprisonment.
The TGA is reminding influencers, affiliates and online sellers that they may be held responsible for promoting unapproved therapeutic goods and should understand their legal obligations.
TGA cracks down on illegal peptide and steroid sales
Source: Therapeutic Goods Administration (TGA), Australian Government.